STN: BL 125070
Proper Name: Rh0(D) Immune Globulin Intravenous (Human)
Tradename: RHOPHYLAC
Manufacturer: CSL Behring AG, License #1766
Indication:

RHOPHYLAC is Rh(D) Immune Globulin Intravenous (Human) indicated for: Suppression of Rhesus (Rh) Isoimmunization in:

  • Pregnancy and obstetric conditions in non-sensitized, Rh(D)-negative women with an Rh-incompatible pregnancy, including:
    • Routine antepartum and postpartum Rh prophylaxis
    • Rh prophylaxis in obstetric complications or invasive procedures
  • Incompatible transfusions in Rh(D)-negative individuals transfused with blood components containing Rh(D)-positive red blood cells (RBCs)

Immune Thrombocytopenic Purpura (ITP) 

  • Raising platelet counts in Rh(D)-positive, non-splenectomized adults with chronic ITP.

Product Information

Supporting Documents

  • Content current as of:

    07/30/2025

Source

Clinical :: Oncology :: Nuclear :: Geriatric :: Regulatory :: Technology :: Consulting

"My passion is helping businesses, small and large, perform at their best." - Felicia Udoji-Eddings, Pharm.D.

Dr. Felicia Udoji-Eddings is the Founder and CEO of The Health Pals Company, a vertically integrated Healthcare System. As an experienced Clinical Pharmacy Leader, Pharmacy Consultant, Healthcare Executive, and Licensed Pharmacy Practitioner with deep backgrounds in Information Technology (IT), Scientific Research, and Business Management. Dr. Udoji-Eddings has a strong track record of exceptional performance in different business environments. A skilled Business Strategist, Dr. Udoji-Eddings has tackled complex problems and helped several organizations refocus their strategy in tough economic times. As a highly motivated and proactive individual, Felicia enjoys working with teams, in various capacities, to facilitate positive outcomes.